CoChat

CA1 Nampt knockdown recapitulates hippocampal cognitive phenotypes in old mice which nicotinamide mononucleotide improves

Open access
Johnson, Sean, Wozniak, David F., Imai, S. · 2018 · npj Aging and Mechanisms of Disease

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Abstract

Cognitive dysfunction is one of the most concerning outcomes in global population aging. However, the mechanisms by which cognitive functions are impaired during aging remain elusive. It has been established that NAD+ levels are reduced in multiple tissues and organs, including the brain. We found that NAD+ levels declined in the hippocampus of mice during the course of aging, and whereas we observed minimal age-related effects on spatial learning/memory capabilities in old mice, we discovered that they developed cognitive hypersensitivity in response to aversive stimulation during contextual fear conditioning tests. This cognitive hypersensitivity appears to be associated with alterations in emotionality (fear/anxiety) and sensory processing (shock sensitivity), rather than reflect genuine conditioning/retention effects, during aging. Supplementation of nicotinamide mononucleotide (NMN) improved the sensory processing aspect of the hypersensitivity and possibly other related behaviors. Specific knockdown of nicotinamide phosphoribosyltransferase (Nampt) in the CA1 region, but not in the dentate gyrus, recapitulates this cognitive hypersensitivity observed in old mice. We identified calcium/calmodulin-dependent serine protein kinase (Cask) as a potential downstream effector in response to age-associated NAD+ reduction in the hippocampus. Cask expression is responsive to NAD+ changes and also reduced in the hippocampus during aging. Short-term NMN supplementation can enhance Cask expression in the hippocampus of old mice. Its promoter activity is regulated in a Sirt1-dependent manner. Taken together, NAD+ reduction in the CA1 region contributes to development of age-associated cognitive dysfunction, aspects of which may be prevented or treated by enhancing NAD+ availability through supplementation of NAD+ intermediates, such as NMN.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41514-018-0029-z

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Old mice show significant decreases in hippocampal NAD+ levels but retain their spatial acquisition and learning capabilities. a Hippocampal NAD+ levels in male mice at 2, 7, and 19 months of age (n = 6; *p < 0.05, one-way ANOVA with LSD post hoc test). b Total ambulations were measured in the 1 h locomotor activity tests on PBS-treated 2-month-old (n = 12), PBS-treated 20-month-old (n = 14), and NMN-treated 20-month-old (n = 14) male mice. c–h Evaluation of PBS-treated 2-month-old (n = 12), PBS-treated 20-month-old (n = 14), and NMN-treated 20-month-old (n = 14) male mice in the MWM tests. Escape path lengths and swimming speeds during the cued (c, d) and place (e, f) conditions are shown. Platform crossings (g) and times spent in each quadrant (h) during the probe condition are also shown. Data are presented as mean ± SE. Statistical analyses were conducted by two-way repeated measures ANOVA for (b–f) and one-way ANOVA for (a, g, h). Significant group effects and group by time or sessions interactions are denoted by symbols at the right sides of the graphs (§ and †, respectively). b–f *p < 0.05, **, ##, $$p < 0.01, ***, ###p < 0.001 (*, **, *** for PBS-treated young vs. PBS-treated old mice; #, ## for PBS-treated young vs. NMN-treated old mice; $$ for PBS-treated old vs. NMN-treated old mice). g *p < 0.05 for the comparison to PBS-treated young mice. h Significant spatial bias toward the target quadrant is denoted (*)
Fig. 1 Old mice show significant decreases in hippocampal NAD+ levels but retain their spatial acquisition and learning capabilities. a Hippocampal NAD+ levels in male mice at 2, 7, and 19 months of age (n = 6; *p < 0.05, one-way ANOVA with LSD post hoc test). b Total ambulations were measured in the 1 h locomotor activity tests on PBS-treated 2-month-old (n = 12), PBS-treated 20-month-old (n = 14), and NMN-treated 20-month-old (n = 14) male mice. c–h Evaluation of PBS-treated 2-month-old (n = 12), PBS-treated 20-month-old (n = 14), and NMN-treated 20-month-old (n = 14) male mice in the MWM tests. Escape path lengths and swimming speeds during the cued (c, d) and place (e, f) conditions are shown. Platform crossings (g) and times spent in each quadrant (h) during the probe condition are also shown. Data are presented as mean ± SE. Statistical analyses were conducted by two-way repeated measures ANOVA for (b–f) and one-way ANOVA for (a, g, h). Significant group effects and group by time or sessions interactions are denoted by symbols at the right sides of the graphs (§ and †, respectively). b–f *p < 0.05, **, ##, $$p < 0.01, ***, ###p < 0.001 (*, **, *** for PBS-treated young vs. PBS-treated old mice; #, ## for PBS-treated young vs. NMN-treated old mice; $$ for PBS-treated old vs. NMN-treated old mice). g *p < 0.05 for the comparison to PBS-treated young mice. h Significant spatial bias toward the target quadrant is denoted (*)CC BY · PubMed Central
Fig. 2 Old mice exhibit cognitive hypersensitivity, aspects of which are improved by NMN. a–c Contextual fear conditioning tests were conducted on PBS-treated 2-month-old (n = 12), PBS-treated 20-month-old (n = 14), and NMN-treated 20-month-old (n = 14) male mice. Values of percent time freezing are shown for baseline and tone-shock (CS-US) training periods on day 1 (a), contextual fear conditioning on day 2 (b), and the auditory cue period on day 3 (c). Statistical analyses were conducted by two-way repeated measures (rm) ANOVA, and differences at each time point were evaluated by one-way ANOVA. d Shock sensitivities for flinch response, vocalization, and escape response are shown for the same groups of mice used in (a–c). Data are presented as mean ± SE. Significant group effects and group by time interactions are denoted by symbols at the right sides of the graphs (§ and †, respectively); #p < 0.05, **, ##p < 0.01, ***, ###, $$$p < 0.001 (**, *** for PBS-treated young vs. PBS-treated old mice; #, ##, ### for PBS-treated young vs. NMN-treated old mice; $$$ for PBS-treated old vs. NMN-treated old mice)
Fig. 2 Old mice exhibit cognitive hypersensitivity, aspects of which are improved by NMN. a–c Contextual fear conditioning tests were conducted on PBS-treated 2-month-old (n = 12), PBS-treated 20-month-old (n = 14), and NMN-treated 20-month-old (n = 14) male mice. Values of percent time freezing are shown for baseline and tone-shock (CS-US) training periods on day 1 (a), contextual fear conditioning on day 2 (b), and the auditory cue period on day 3 (c). Statistical analyses were conducted by two-way repeated measures (rm) ANOVA, and differences at each time point were evaluated by one-way ANOVA. d Shock sensitivities for flinch response, vocalization, and escape response are shown for the same groups of mice used in (a–c). Data are presented as mean ± SE. Significant group effects and group by time interactions are denoted by symbols at the right sides of the graphs (§ and †, respectively); #p < 0.05, **, ##p < 0.01, ***, ###, $$$p < 0.001 (**, *** for PBS-treated young vs. PBS-treated old mice; #, ##, ### for PBS-treated young vs. NMN-treated old mice; $$$ for PBS-treated old vs. NMN-treated old mice)CC BY · PubMed Central
Fig. 3 CA1-specific Nampt knockdown recapitulates cognitive hypersensitivity observed in old mice. a Nampt mRNA levels in the CA1, CA3, and DG regions of CA1-specific Nampt knockdown and GFP-injected control mice (n = 3 mice for each group; *p < 0.05, unpaired Student’s t-test). b Total ambulations were quantified during the 1 h locomotor activity test conducted on CA1-specific Nampt knockdown mice (n = 8) and GFP-injected control mice (n = 7). c, d Analysis of the MWM probe trial data did not reveal any significant differences between CA1-specific Nampt knockdown (n = 8) and GFP-injected control (n = 7) mice (unpaired Student's t-test, two-way rmANOVA). e–g Contextual fear conditioning tests were conducted on CA1-specific Nampt knockdown (n = 8) and GFP-injected control (n = 7) male mice. Values of percent time freezing are shown from the tone-shock (CS-US) training period on day 1 (e), contextual fear conditioning on day 2 (f), and the auditory cue period on day 3 (g). Statistical analyses were conducted by two-way rmANOVA, and significant group effects are denoted by a symbol (§) at the right sides of the graphs; *p < 0.05, **p < 0.01, ***p < 0.001. h Shock sensitivities for flinch response, vocalization, and escape response are shown for the same groups of mice used in (e–g) (*p < 0.05, unpaired Student’s t-test). Data are presented as mean ± SE
Fig. 3 CA1-specific Nampt knockdown recapitulates cognitive hypersensitivity observed in old mice. a Nampt mRNA levels in the CA1, CA3, and DG regions of CA1-specific Nampt knockdown and GFP-injected control mice (n = 3 mice for each group; *p < 0.05, unpaired Student’s t-test). b Total ambulations were quantified during the 1 h locomotor activity test conducted on CA1-specific Nampt knockdown mice (n = 8) and GFP-injected control mice (n = 7). c, d Analysis of the MWM probe trial data did not reveal any significant differences between CA1-specific Nampt knockdown (n = 8) and GFP-injected control (n = 7) mice (unpaired Student's t-test, two-way rmANOVA). e–g Contextual fear conditioning tests were conducted on CA1-specific Nampt knockdown (n = 8) and GFP-injected control (n = 7) male mice. Values of percent time freezing are shown from the tone-shock (CS-US) training period on day 1 (e), contextual fear conditioning on day 2 (f), and the auditory cue period on day 3 (g). Statistical analyses were conducted by two-way rmANOVA, and significant group effects are denoted by a symbol (§) at the right sides of the graphs; *p < 0.05, **p < 0.01, ***p < 0.001. h Shock sensitivities for flinch response, vocalization, and escape response are shown for the same groups of mice used in (e–g) (*p < 0.05, unpaired Student’s t-test). Data are presented as mean ± SECC BY · PubMed Central
Fig. 4 DG-specific Nampt knockdown mice do not show cognitive hypersensitivity. a Nampt mRNA levels in the CA1, CA3, and DG regions of DG-specific Nampt knockdown and GFP-injected control mice (n = 3 mice for each group; *p < 0.05, unpaired Student’s t-test). b–d Contextual fear conditioning tests were conducted on DG-specific Nampt knockdown (n = 7) and GFP-injected control (n = 6) mice. No significant main effects of group or group by time interactions were found from the analyses conducted for any of the components of the fear conditioning procedure. Values of percent time freezing are shown from the tone-shock (CS-US) training period on day 1 (b), contextual fear conditioning on day 2 (c), and the auditory cue period on day 3 (d). No statistical differences were detected by two-way rmANOVA. Data are presented as mean ± SE
Fig. 4 DG-specific Nampt knockdown mice do not show cognitive hypersensitivity. a Nampt mRNA levels in the CA1, CA3, and DG regions of DG-specific Nampt knockdown and GFP-injected control mice (n = 3 mice for each group; *p < 0.05, unpaired Student’s t-test). b–d Contextual fear conditioning tests were conducted on DG-specific Nampt knockdown (n = 7) and GFP-injected control (n = 6) mice. No significant main effects of group or group by time interactions were found from the analyses conducted for any of the components of the fear conditioning procedure. Values of percent time freezing are shown from the tone-shock (CS-US) training period on day 1 (b), contextual fear conditioning on day 2 (c), and the auditory cue period on day 3 (d). No statistical differences were detected by two-way rmANOVA. Data are presented as mean ± SECC BY · PubMed Central
Fig. 5 Cask expression is NAD+ sensitive and reduced in the hippocampus during aging. a Cellular NAD+ levels in primary hippocampal neurons treated with DMSO or FK866 at 10 nM and 100 nM for 48 h (n = 12; **p < 0.01, one-way ANOVA with LSD post hoc test). b Cell viability was assessed by measuring LDH in the supernatants from primary hippocampal neurons treated with DMSO or FK866 at 100 nM for 48 h (n = 6). c Cask mRNA levels in primary hippocampal neurons after treatment with FK866 (100 nM) or FK866 (100 nM) plus NMN (100 μM). Expression levels were normalized to those of DMSO-treated control cells (n = 9; *p < 0.05, one-way ANOVA with LSD post hoc test). d Cask mRNA levels in whole hippocampal ex vivo cultures after treatment with DMSO or FK866 (100 nM) (n = 3 for each condition; *p < 0.05, unpaired Student’s t-test). e mRNA levels of Cask and Nampt in hippocampi of 2-month-old (Y) and 20-month-old (O) mice (n = 3; *p < 0.05, unpaired Student’s t-test). f mRNA levels of Cask, GluN1, GluN2A, GluN2B, Kif17, Lin7C, Abpa1, and Nampt in hippocampi of 20-month-old male mice treated with NMN (300 mg/kg/day) for 1 week. mRNA levels were normalized to those of PBS-treated control mice (n = 5; *p < 0.05, unpaired Student’s t-test). Data are presented as mean ± SE
Fig. 5 Cask expression is NAD+ sensitive and reduced in the hippocampus during aging. a Cellular NAD+ levels in primary hippocampal neurons treated with DMSO or FK866 at 10 nM and 100 nM for 48 h (n = 12; **p < 0.01, one-way ANOVA with LSD post hoc test). b Cell viability was assessed by measuring LDH in the supernatants from primary hippocampal neurons treated with DMSO or FK866 at 100 nM for 48 h (n = 6). c Cask mRNA levels in primary hippocampal neurons after treatment with FK866 (100 nM) or FK866 (100 nM) plus NMN (100 μM). Expression levels were normalized to those of DMSO-treated control cells (n = 9; *p < 0.05, one-way ANOVA with LSD post hoc test). d Cask mRNA levels in whole hippocampal ex vivo cultures after treatment with DMSO or FK866 (100 nM) (n = 3 for each condition; *p < 0.05, unpaired Student’s t-test). e mRNA levels of Cask and Nampt in hippocampi of 2-month-old (Y) and 20-month-old (O) mice (n = 3; *p < 0.05, unpaired Student’s t-test). f mRNA levels of Cask, GluN1, GluN2A, GluN2B, Kif17, Lin7C, Abpa1, and Nampt in hippocampi of 20-month-old male mice treated with NMN (300 mg/kg/day) for 1 week. mRNA levels were normalized to those of PBS-treated control mice (n = 5; *p < 0.05, unpaired Student’s t-test). Data are presented as mean ± SECC BY · PubMed Central
Fig. 6 Cask promoter activity is regulated in an NAD+/SIRT1-dependent manner. a The ~2 kb upstream region of the Cask gene is schematically shown. There are two potential Oct-1 binding sites. b, c Relative luciferase activities driven by an ~2 kb Cask promoter fragment were measured in HEK293 cells cotransfected with the reporter construct and a Sirt1 minigene (b) or its promoter-only control vector (c) with treatment of FK866 (100 nM), FK866 (100 nM) plus NMN (100 μM), NMN (100 μM), or EX527 (10 μM). Luciferase activities were normalized to those of DMSO-treated control cells (n = 9; *p < 0.05, one-way ANOVA with LSD post hoc test). Data are presented as mean ± SE. d A proposed model for the relationship between age-associated, NAD+/SIRT1-mediated reduction in Cask expression and cognitive hypersensitivity in old mice
Fig. 6 Cask promoter activity is regulated in an NAD+/SIRT1-dependent manner. a The ~2 kb upstream region of the Cask gene is schematically shown. There are two potential Oct-1 binding sites. b, c Relative luciferase activities driven by an ~2 kb Cask promoter fragment were measured in HEK293 cells cotransfected with the reporter construct and a Sirt1 minigene (b) or its promoter-only control vector (c) with treatment of FK866 (100 nM), FK866 (100 nM) plus NMN (100 μM), NMN (100 μM), or EX527 (10 μM). Luciferase activities were normalized to those of DMSO-treated control cells (n = 9; *p < 0.05, one-way ANOVA with LSD post hoc test). Data are presented as mean ± SE. d A proposed model for the relationship between age-associated, NAD+/SIRT1-mediated reduction in Cask expression and cognitive hypersensitivity in old miceCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 46 references

Cited by

See all 57

Metadata

Authors
Johnson, S., Wozniak, D. F., & Imai, S.
Affiliations
Washington University in St. Louis (US)
Corresponding author
Imai, S.
Venue
npj Aging and Mechanisms of Disease
Published
2018-11-08
Volume
4
Issue
1
Pages
10-10
ISSN
2056-3973 (ISSN-L)
OpenAlex
W2898655244
Cited by
57
References
46
Citations by year
2026: 3 · 2025: 5 · 2024: 8 · 2023: 7 · 2022: 11 · 2021: 9 · 2020: 9 · 2019: 5
FWCI
3.19
Type
journal article
Language
en
Open access
Licence
Locations
  • npj Aging and Mechanisms of Disease (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Digital Commons@Becker (Washington University School of Medicine) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • American Federation for Aging Research
  • Hope Center for Neurological Disorders
  • National Institute on Aging (AG037457, R01AG037457, R01AG047902, AG047902)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
nicotinamide mononucleotide, visfatin, hippocampal CA1, aging, cognitive impairment, contextual fear conditioning, sensory processing, shock sensitivity, emotionality, CASK, SIRT1, NAD+ supplementation, age-related cognitive impairment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CA1 Nampt knockdown recapitulates hippocampal cognitive phenotypes in old mice which nicotinamide mononucleotide improves. https://app.cochat.ai/papers/10.1038/s41514-018-0029-z
The paper
Johnson, S., Wozniak, D. F., & Imai, S. (2018). CA1 Nampt knockdown recapitulates hippocampal cognitive phenotypes in old mice which nicotinamide mononucleotide improves. npj Aging and Mechanisms of Disease. https://doi.org/10.1038/s41514-018-0029-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.